SAN DIEGO, May 20, 2013 /PRNewswire/ — Enrollment of patients with Type 2 diabetes is underway in Elcelyx Therapeutics' Phase 2b dose-finding clinical trial of product candidate NewMet ™, a delayed-release …
Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin…
When her grandfather died in 1992 from a sudden heart attack, Joyce Malaskovitz went through the expected sadness and grief.
We skipped yesterday’s prompt on Diabetes Blog Week for our regular weekly advice column, so today we bring you two treats: Now, there’s a reality show we in the Diabetes Community could really get into! As always, we appreciate the talent of cartoonist Terry Keelan , a fellow type 1 living in Southern California who is very active with the … (more)
Got questions about navigating life with diabetes? Welcome to our weekly advice column, Ask D’Mine – the place to get some colorful answers from veteran type 1, diabetes This week, Wil takes a look at the perennial question of a “diabetes conspiracy”: does Big Pharma really have our best interests in mind as it goes [...]
Dr Zanariah Hussein… Knowing that early detection of symptoms can significantly reduce the risk of developing complications from diabetes, it is important to provide diabetes prevention education initiatives.
If there’s one enduring thing associated with marijuana use, it’s the phenomenon referred to as “the munchies.” In fact, this was the first real medical use approved for cannabis – the drug could be used to fight appetite suppression in those made nauseous from chemotherapy.
According to an article in the journal ACS Nano , injectable nanoparticles developed at the Massachusetts Institute of Technology may someday eliminate the need for patients with type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.
A newer class of medications used to control blood sugar levels in type 2 diabetics may also improve cardiovascular health.
An extended insulin-release system comprising an injectable gel of nanoparticles may one day help patients with type 1 diabetes manage their condition without having constantly to test their blood-sugar and inject themselves with insulin…